Page 4567 - Week 12 - Thursday, 26 October 2017
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video
6. The Guidelines only outline the use of buprenorphine tablets or sub-lingual wafers (with or without naloxone) and methadone liquid. No other opioids are recommended for use in treatment of opioid dependency.
ACT Health—invoices
(Question No 609)
Mrs Dunne asked the Minister for Health and Wellbeing, upon notice, on 15 September 2017:
Why did it take the Directorate from 11 May to 13 July 2017 to pay invoices for $306 396.20 and $470 250 from Orion Health.
Ms Fitzharris: The answer to the member’’ question is as follows:
The standard payment term for Orion invoices is 30 days. Prior to payment of an invoice ACT Health goes through a process of confirming the goods and services being invoiced were received. The timeframe for the goods receipting activities was slower than usual due to discussions between ACT Health and Orion Health relating to contractual matters. ACT Health maintained communication with Orion Health about the delays in payments of the invoices.
Drugs—pill testing
(Question No 610)
Mrs Dunne asked the Minister for Health and Wellbeing, upon notice, on 15 September 2017:
(1) Further to the answer to QON No E17-553, is the Government negotiating or intending to negotiate with the Ted Noffs Foundation or any other NGO to conduct pill-testing at the Spilt Milk Festival.
(2) What funding is allocated for pill-testing at the Spilt Milk Festival.
(3) What services will be available for any person who takes a tested drug but suffers adverse effects.
(4) What legal indemnity protections will be put in place for the Government or any person or organisation associated with the pill-testing service.
(5) What counselling services will be available or given to persons wishing to take tested drugs.
(6) What psychological screening services will be available for persons wishing to take tested drugs, to determine the likelihood of them entering a psychotic state after taking stimulants (refer to Chapter 7 National Drug Strategy).
(7) What psychological screening services will be available for persons with an existing psychotic disorder, to determine whether their condition will be exacerbated by taking tested drugs (refer to Chapter 7 National Drug Strategy).
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video